The Atypical Inhibitor of NF-κB, IκBζ, Controls Macrophage Interleukin-10 Expression
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Atypical Inhibitor of NF-κB, IκBζ, Controls Macrophage Interleukin-10 Expression
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 291, Issue 24, Pages 12851-12861
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2016-04-19
DOI
10.1074/jbc.m116.718825
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
- (2015) Qian Zhang et al. NATURE
- IκBζ is a key driver in the development of psoriasis
- (2015) Claus Johansen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
- (2014) Brian Ruffell et al. CANCER CELL
- Akirin2 is critical for inducing inflammatory genes by bridging I B- and the SWI/SNF complex
- (2014) S. Tartey et al. EMBO JOURNAL
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration
- (2014) Naoyuki Makita et al. INTERNATIONAL IMMUNOLOGY
- Atypical IκB proteins – nuclear modulators of NF-κB signaling
- (2013) Marc Schuster et al. Cell Communication and Signaling
- Enhanced Apoptosis by Disruption of the STAT3-IκB-ζ Signaling Pathway in Epithelial Cells Induces Sjögren’s Syndrome-like Autoimmune Disease
- (2013) Atsushi Okuma et al. IMMUNITY
- I B is a regulator of the senescence-associated secretory phenotype in DNA damage- and oncogene-induced senescence
- (2013) E. Alexander et al. JOURNAL OF CELL SCIENCE
- I B Is a Transcriptional Key Regulator of CCL2/MCP-1
- (2013) D. G. Hildebrand et al. JOURNAL OF IMMUNOLOGY
- It takes two to tango: IκBs, the multifunctional partners of NF-κB
- (2012) Michael Hinz et al. IMMUNOLOGICAL REVIEWS
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Macrophages and Tissue Injury: Agents of Defense or Destruction?
- (2011) Debra L. Laskin et al. Annual Review of Pharmacology and Toxicology
- I B augments IL-12- and IL-18-mediated IFN- production in human NK cells
- (2011) Y. Kannan et al. BLOOD
- Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level
- (2011) V Graupner et al. CELL DEATH AND DIFFERENTIATION
- Hierarchies of NF-κB target-gene regulation
- (2011) Stephen T Smale NATURE IMMUNOLOGY
- Crosstalk in NF-κB signaling pathways
- (2011) Andrea Oeckinghaus et al. NATURE IMMUNOLOGY
- Selective Transcription in Response to an Inflammatory Stimulus
- (2010) Stephen T. Smale CELL
- IκBζ regulates TH17 development by cooperating with ROR nuclear receptors
- (2010) Kazuo Okamoto et al. NATURE
- Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor B
- (2009) C. Porta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Class-specific Regulation of Pro-inflammatory Genes by MyD88 Pathways and IκBζ
- (2008) Hisako Kayama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Nuclear IκB Protein IκBζ Specifically Binds NF-κB p50 Homodimers and Forms a Ternary Complex on κB DNA
- (2008) Dan V. Trinh et al. JOURNAL OF MOLECULAR BIOLOGY
- The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
- (2008) Alejandro Villagra et al. NATURE IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now